|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95.7 TWD | +0.31% |
|
-1.03% | -14.55% |
| 03-14 | Panion & Bf Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-07 | Panion & Bf Biotech Inc. Approves Cash Dividend for 2023 | CI |
Panion & Bf Biotech Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 2,398.65 million compared to TWD 1,901.21 million a year ago. Net income was TWD 182.35 million compared to TWD 104.4 million a year ago.
Basic earnings per share from continuing operations was TWD 2.13 compared to TWD 1.32 a year ago. Diluted earnings per share from continuing operations was TWD 2.12 compared to TWD 1.32 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.55% | 253M | |
| +31.37% | 588B | |
| -3.12% | 364B | |
| +19.57% | 326B | |
| +5.16% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.76% | 167B | |
| +0.52% | 161B |
PANION & BF BIOTECH INC. 
